long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
Published 2 years ago • 86 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:40
long-term follow-up of the tourmaline-mm1 trial
-
1:08
long term follow-up results from the phase iii maia trial in myeloma
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
0:46
2-year follow-up of majestec-1: teclistamab in r/r multiple myeloma
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
2:06
long-term follow-up from the uk myeloma xi trial
-
2:36
what does the tourmaline-mm2 study tell us about the use of ixazomib in multiple myeloma?
-
7:15
endeavour, aspire and tourmaline-mm1 trial results for multiple myeloma
-
1:00:53
how fast can multiple myeloma progress and what biologically happens when it does?
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
8:22
multiple myeloma - when doctor becomes a patient.
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
2:32
updates on the use of melflufen in r/r multiple myeloma
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
1:44
optimal treatment sequencing in multiple myeloma
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:30
real-world treatment patterns in third-line therapy for r/r myeloma
-
0:56
why one size should not fit all for multiple myeloma
-
1:32
the use of belantamab mafodotin in triplet combinations for multiple myeloma
-
7:19
tourmaline-mm2: clinically meaningful results in multiple myeloma trial
-
6:33
the phase 3 tourmaline-mm2 trial